Remove Capital Remove Company Remove Thousand Oaks Remove Venture Capital
article thumbnail

Amgen's Kevin Sharer Joins Healthcare Venture Capital Firm

socalTECH

Is Amgen the next source of the healthcare industry's venture capital deals? It might be, on news that Kevin Sharer , the former CEO of Thousand Oaks-based Amgen , has joined venture capital investment firm Foundation Medical Partners. READ MORE>>.

article thumbnail

Amgen Ventures Backs Akili In $55M Funding

socalTECH

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , is one of the investors in a Boston biotech company, Akili Interactive. Akili is developing digital medicine products aimed at treating cognitive dysfunction, including ADHD, multiple sclerosis, and depression. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Xirrus Raises $10M More

socalTECH

Thousand Oaks-based wireless hardware provider Xirrus has raised yet another $10M in funding, according to a regulatory filing from the company Monday. Details on the funding have not yet been announced by the company. The company apparently is targeting a little over $11.0M Venture Partners. READ MORE>>.

article thumbnail

Capsida Uncloaks With $140M In Funding

socalTECH

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

article thumbnail

Amgen Co-Founder Bowes Passes Away

socalTECH

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th. Bowes, Jr. , Amgen said that "without Bowes, there would be no Amgen". Bowes retired from Amgen's board in 2002.

article thumbnail

Dantari Gets $47M For Tumor Medicine Effort

socalTECH

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. Markus, M.D., a co-founding managing director at Westlake.

article thumbnail

Amgen Backed Alector Adds $133M

socalTECH

South San Francisco-based Alector , a biotechnology company focused on finding treatments for neurodegenerative diseases and cancer, announced Wednesday that it has raised $133M in a Series E funding round. Alector said the financing will go to advance its clinical programs and expand the company's discovery platform. READ MORE>>.